ZA90637B - Heterocyclic nitromethane derivatives - Google Patents

Heterocyclic nitromethane derivatives

Info

Publication number
ZA90637B
ZA90637B ZA90637A ZA90637A ZA90637B ZA 90637 B ZA90637 B ZA 90637B ZA 90637 A ZA90637 A ZA 90637A ZA 90637 A ZA90637 A ZA 90637A ZA 90637 B ZA90637 B ZA 90637B
Authority
ZA
South Africa
Prior art keywords
ring
phenyl
alkyl
atoms
optionally substituted
Prior art date
Application number
ZA90637A
Other languages
English (en)
Inventor
Keith Blakeney Mallion
Blakeney Mallion Keith
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA90637B publication Critical patent/ZA90637B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA90637A 1989-02-03 1990-01-29 Heterocyclic nitromethane derivatives ZA90637B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898902405A GB8902405D0 (en) 1989-02-03 1989-02-03 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ZA90637B true ZA90637B (en) 1990-10-31

Family

ID=10651067

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90637A ZA90637B (en) 1989-02-03 1990-01-29 Heterocyclic nitromethane derivatives

Country Status (15)

Country Link
US (1) US5096918A (fr)
EP (1) EP0408714B1 (fr)
JP (1) JPH03503900A (fr)
AT (1) ATE100797T1 (fr)
AU (1) AU631400B2 (fr)
CA (1) CA2025664A1 (fr)
DE (1) DE69006274D1 (fr)
GB (1) GB8902405D0 (fr)
GR (1) GR1000444B (fr)
IE (1) IE900255L (fr)
IL (1) IL93177A0 (fr)
NZ (1) NZ232348A (fr)
PT (1) PT93051A (fr)
WO (1) WO1990008762A1 (fr)
ZA (1) ZA90637B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250570A (en) * 1990-08-02 1993-10-05 Imperial Chemical Industries Plc Amidobenzene derivatives, compositions and use
JPH05255089A (ja) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
CA2145640C (fr) * 1992-09-28 2001-01-30 Banavara L. Mylari Pyrimidines substituees pour la maitrise des complications du diabete
US5516534A (en) * 1993-11-26 1996-05-14 Rensselaer Polytechnic Institute Composition and method for reducing structural defects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1229653A (fr) * 1968-03-14 1971-04-28
US4053633A (en) * 1976-06-24 1977-10-11 The Dow Chemical Company Aryl dibromonitromethyl sulfones
GB8718619D0 (en) * 1987-08-06 1987-09-09 Ici Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
DE69006274D1 (de) 1994-03-10
GB8902405D0 (en) 1989-03-22
WO1990008762A1 (fr) 1990-08-09
GR900100067A (en) 1991-06-28
JPH03503900A (ja) 1991-08-29
NZ232348A (en) 1992-04-28
GR1000444B (el) 1992-07-30
IL93177A0 (en) 1990-11-05
EP0408714B1 (fr) 1994-01-26
AU5020890A (en) 1990-08-24
ATE100797T1 (de) 1994-02-15
CA2025664A1 (fr) 1990-08-04
IE900255L (en) 1990-08-03
EP0408714A1 (fr) 1991-01-23
AU631400B2 (en) 1992-11-26
US5096918A (en) 1992-03-17
PT93051A (pt) 1990-08-31

Similar Documents

Publication Publication Date Title
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
ES478871A1 (es) Un procedimiento de preparacion de 2,6-dialcoxibenzamidas.
ES485798A1 (es) Un procedimiento para la preparacion de nuevos acidos benzo-piran y benzotiopiran-4-carboxilicos y derivados de los mis-mos.
IL93177A0 (en) Heterocyclic nitromethane derivatives
AU532411B2 (en) Phenyl piperazine derivatives
SE7605190L (sv) Nya tiazoliner
AU576887B2 (en) 1,6-naphthyridine derivatives
NZ216125A (en) Isoxazoles and pharmaceutical compositions
AU586485B2 (en) New thieno-1,2-thiazole derivatives, a process for their prepaeration and pharmaceutical products containing these compounds
IL93178A0 (en) Benzheterocyclyl sulphones
ES508415A0 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
JPS5699479A (en) Antipsychotic
JPS56133292A (en) Novel derivatives of cycloheptoindole, salts with their acids, their manufacture, application as drug and composition containing them
MY102282A (en) Isoxazole derivatives with antiviral activities and pharmaceutical products containing these.
AU601942B2 (en) New esters derived from 4-hydroxy-3-quinoline carboxylic acid substituted by an alpha-hydroxyl chain at position 2, their preparation, their use as a medicament and the compositions containing them